(Q36621610)

15 August 2017

Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells (English)

1 reference

15 August 2017

Ragnarsson GB

1

1 reference

15 August 2017

Mikaelsdottir EK

2

1 reference

15 August 2017

Vidarsson H

3

1 reference

15 August 2017

Jónasson JG

4

1 reference

15 August 2017

Olafsdóttir K

5

1 reference

15 August 2017

Kristjánsdóttir K

6

1 reference

15 August 2017

Kjartansson J

7

1 reference

15 August 2017

Ogmundsdóttir HM

8

1 reference

15 August 2017

Rafnar T

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

83

1 reference

15 August 2017

12

1 reference

15 August 2017

1715-1721

1 reference

https://scigraph.springernature.com/pub.10.1054/bjoc.2000.1506

15 August 2017

0 references

cites work

Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

The Fas counterattack: cancer as a site of immune privilege

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Human melanoma cells do not express Fas (Apo-1/CD95) ligand

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Human lung carcinomas express Fas ligand.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Apoptosis by death factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Tumour-associated leucocytes: friends or foes in breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

The host-tumor immune conflict: from immunosuppression to resistance and destruction

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363445

Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules

20 September 2018

1 reference

12 December 2020

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

12 December 2020

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

12 December 2020

Apoptosis of crypt epithelial cells in ulcerative colitis

1 reference

12 December 2020

Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies

1 reference

12 December 2020

Soluble Fas and soluble Fas ligand proteins in human milk: possible significance in the development of immunological tolerance

1 reference

12 December 2020

Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas

1 reference

12 December 2020

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells

1 reference

12 December 2020

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo

1 reference

12 December 2020

A role for CD95 ligand in preventing graft rejection

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2000.1506

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11104571

1 reference